Etodolac
- Product NDC
- 60505-0039
- 11-digit product format
- 605050039
- Labeler code
- 60505
- Product ID
- 60505-0039_41e18dea-7642-9715-53b0-db2b46d8265b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Etodolac
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Apotex Corp.
- Application
- ANDA075419
- Marketing category
- ANDA
- Marketing start
- 2003-05-01
- Substance
- ETODOLAC
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Etodolac
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ETODOLAC | 200 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 2M36281008 |
| Rxcui | 197684, 197685 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bb9faa76-10d1-4b5f-ab9b-d6a26495edb7 | Product name | 1 | 20250311 |
| 0c3d95a8-02c3-425e-810b-2a14408d9a06 | Product name | 4 | 20250218 |
| 24aa5265-325f-0e21-8836-2c9a907c0454 | Product name | 2 | 20210601 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-0039-1 | Etodolac | 100 in 1 BOTTLE | CAPSULE | 100 | 13 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-0039-1 | EA - Each | 60505-0039 | d7964b66-79ba-4049-a727-42c045c1d78c | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ETODOLAC | ACTIVE INGREDIENT | 2M36281008 | ETODOLAC CAPSULE [APOTEX CORP.] | 2 | |
| ETODOLAC | ACTIVE MOIETY | 2M36281008 | ETODOLAC CAPSULE [APOTEX CORP.] | 2 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ETODOLAC CAPSULE [APOTEX CORP.] | 2 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | ETODOLAC CAPSULE [APOTEX CORP.] | 2 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | ETODOLAC CAPSULE [APOTEX CORP.] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ETODOLAC CAPSULE [APOTEX CORP.] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ETODOLAC CAPSULE [APOTEX CORP.] | 2 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | ETODOLAC CAPSULE [APOTEX CORP.] | 2 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | ETODOLAC CAPSULE [APOTEX CORP.] | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ETODOLAC CAPSULE [APOTEX CORP.] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ETODOLAC CAPSULE [APOTEX CORP.] | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-0039 | ETODOLAC CAPSULE [APOTEX CORP.] | 12 | Current NDC, Legacy NDC, 1 package rows | 20240809_86c7b7b8-3a98-e5f4-c558-5b5caede6377.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197684 | etodolac 200 MG Oral Capsule | PSN | 86c7b7b8-3a98-e5f4-c558-5b5caede6377 | 13 |
| 197685 | etodolac 300 MG Oral Capsule | PSN | 86c7b7b8-3a98-e5f4-c558-5b5caede6377 | 13 |
| 197684 | etodolac 200 MG Oral Capsule | SCD | 86c7b7b8-3a98-e5f4-c558-5b5caede6377 | 13 |
| 197685 | etodolac 300 MG Oral Capsule | SCD | 86c7b7b8-3a98-e5f4-c558-5b5caede6377 | 13 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 60505-0039-1 | 60505003901 | 100 CAPSULE in 1 BOTTLE (60505-0039-1) | 100 capsule | 2003-05-01 | 0000-00-00 | No | No | Current |